From early development to manufacture
Cell and gene therapies offer potential cures for some of the most devastating and challenging conditions of our time. TTP is enabling leading companies to commercialize and realize the full potential of their innovative cell therapies.
By using disruptive technologies and automation, TTP is advancing research, development, and manufacturing processes to make living medicines a reality for patients everywhere.
We combine expertise in biology, physics and engineering to provide your team with specialist capabilities and transformative technologies in cell and gene therapy.
We develop bespoke solutions and disruptive new technologies for cell and gene therapies. Our inventions to help clients to commercialise their products, reduce costs and complexities, while also improving access and scalability of their ideas.
Partner for success
We work as an extension of your team, supporting you to challenge conventional thinking. Together, we can create and accelerate existing ideas into successful and commercially viable cell and gene therapies.
For over 30 years we have been supporting clients with the development and commercialisation of cell and gene therapies. To date, we have completed over 20 projects for leading companies, enabling cell therapy automation and improving cell therapy manufacturing. Our heritage allows us to anticipate and solve potential challenges across the entire development process.
Commercialising Cell Therapies
Cell Therapy as a Medical Device (CTMD) is our approach to help clients commercialise cell therapies. It combines our medical device development capability with our extensive experience of bioprocessing, cell handling and maintenance. We support companies to create bespoke manufacturing facilities, reduce cost of goods, and address variability and safety challenges, while scaling up new innovations.